Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A S Bloom

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Dementia (Basel, Switzerland)|July 1, 1995
Leukocyte hexokinase activity in aging and Alzheimer diseaseP G Antuono, J Ravanelli-Meyer, K Nicholson, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|January 1, 1988
Methylphenidate-induced delusional disorder in a child with attention deficit disorder with hyperactivityA S Bloom, L J Russell, B Weisskopf, et al.
Pharmacology, Biochemistry, and Behavior|August 1, 1997
Cannabinoid-induced alterations in regional cerebral blood flow in the ratA S Bloom, S Tershner, S A Fuller, et al.
Journal of Clinical Psychology|January 1, 1978
The assessment of developmentally disabled children with the WISC-R, Binet and other testsL M Raskin, A S Bloom, S H Klee, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1990
Studies of the role of membrane lipid order in the effects of delta 9-tetrahydrocannabinol on adenylate cyclase activation in heartC J Hillard, J J Pounds, D R Boyer, et al.
Neuroendocrinology|September 1, 1981
Effect of intraventricular beta-endorphin and morphine on hypothalamic-pituitary-adrenal activity and the release of pituitary beta-endorphinJ L Haracz, A S Bloom, R I Wang, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1977
9-nor-9beta-hydroxyhexahydrocannabinol, a cannabinoid with potent antinociceptive activity: comparisons with morphineA S Bloom, W L Dewey, L S Harris, et al.
Pharmacology, Biochemistry, and Behavior|April 1, 1984
The effects of delta 9-tetrahydrocannabinol on serum thyrotropin levels in the ratC J Hillard, N E Farber, T C Hagen, et al.
Journal of Autism and Developmental Disorders|July 7, 2001
Brief report: case reports on naltrexone use in children with autism: controlled observations regarding benefits and practical issues of medication managementP G Williams, A Allard, L Sears, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1976
The correlation between antinociceptive activity of narcotics and their antagonists as measured in the mouse tail-flick test and increased synthesis of brain catecholaminesA S Bloom, W L Dewey, L S Harris, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Dementia (Basel, Switzerland)|July 1, 1995
Leukocyte hexokinase activity in aging and Alzheimer diseaseP G Antuono, J Ravanelli-Meyer, K Nicholson, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|January 1, 1988
Methylphenidate-induced delusional disorder in a child with attention deficit disorder with hyperactivityA S Bloom, L J Russell, B Weisskopf, et al.
Pharmacology, Biochemistry, and Behavior|August 1, 1997
Cannabinoid-induced alterations in regional cerebral blood flow in the ratA S Bloom, S Tershner, S A Fuller, et al.
Journal of Clinical Psychology|January 1, 1978
The assessment of developmentally disabled children with the WISC-R, Binet and other testsL M Raskin, A S Bloom, S H Klee, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1990
Studies of the role of membrane lipid order in the effects of delta 9-tetrahydrocannabinol on adenylate cyclase activation in heartC J Hillard, J J Pounds, D R Boyer, et al.
Neuroendocrinology|September 1, 1981
Effect of intraventricular beta-endorphin and morphine on hypothalamic-pituitary-adrenal activity and the release of pituitary beta-endorphinJ L Haracz, A S Bloom, R I Wang, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1977
9-nor-9beta-hydroxyhexahydrocannabinol, a cannabinoid with potent antinociceptive activity: comparisons with morphineA S Bloom, W L Dewey, L S Harris, et al.
Pharmacology, Biochemistry, and Behavior|April 1, 1984
The effects of delta 9-tetrahydrocannabinol on serum thyrotropin levels in the ratC J Hillard, N E Farber, T C Hagen, et al.
Journal of Autism and Developmental Disorders|July 7, 2001
Brief report: case reports on naltrexone use in children with autism: controlled observations regarding benefits and practical issues of medication managementP G Williams, A Allard, L Sears, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1976
The correlation between antinociceptive activity of narcotics and their antagonists as measured in the mouse tail-flick test and increased synthesis of brain catecholaminesA S Bloom, W L Dewey, L S Harris, et al.
Pageof 6